LNTH May 2024 55.000 call
- GlobeNewswire
Lantheus Announces Executive Appointments to Accelerate Innovation
Jeffrey S. Humphrey, MD appointed Chief Medical Officer;Jean-Claude Provost, MD named Chief Science Officer BEDFORD, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Jeffrey S. Humphrey, MD has been appointed Chief Medical Officer (CMO) and Jean-Claude Provost, MD has been named Chief Sci
- Zacks
Here is What to Know Beyond Why Lantheus Holdings, Inc. (LNTH) is a Trending Stock
Lantheus Holdings (LNTH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- Simply Wall St.
Lantheus Holdings, Inc. Just Beat EPS By 60%: Here's What Analysts Think Will Happen Next
Lantheus Holdings, Inc. ( NASDAQ:LNTH ) defied analyst predictions to release its quarterly results, which were ahead...
